One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Pediatric Inflammatory Bowel Disease Type Unclassified: A Nationwide Cohort Study in Scotland With up to 20 Years Follow-up Shows Reclassification in the Majority and Mild Course in Those Whose Diagnosis Is Unchanged
doi : 10.1093/ibd/izae218
Volume 31, Issue 2, February 2025
Microbial and Transcriptomic Landscape Associated With Neutrophil Extracellular Traps in Perianal Fistulizing Crohn’s Disease
doi : 10.1093/ibd/izae202
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study Open Access
doi : 10.1093/ibd/izae095
Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease
doi : 10.1093/ibd/izae219
Increased Risk of Inflammatory Bowel Disease Among Patients With Nontyphoidal Salmonella Infections: A Population-Based Cohort Study Free
doi : 10.1093/ibd/izae053
Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease
doi : 10.1093/ibd/izae126
Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019 Free
doi : 10.1093/ibd/izae093
Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population Open Access
doi : 10.1093/ibd/izae188
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn’s Disease Open Access
doi : 10.1093/ibd/izae200
Following Through: The Impact of Culinary Medicine on Mediterranean Diet Uptake in Inflammatory Bowel Disease
doi : 10.1093/ibd/izae141
Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey Open Access
doi : 10.1093/ibd/izae119
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
doi : 10.1093/ibd/izae112
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn’s Disease in the Phase 2 AMAG Study Open Access
doi : 10.1093/ibd/izae166
Gender and Sex Differences in Abdominal Pain, Fatigue, And Psychological Symptoms Among Adults with Inflammatory Bowel Disease: A Network Analysis
doi : 10.1093/ibd/izae279
Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease
doi : 10.1093/ibd/izae158
Efficacy of Ustekinumab and Vedolizumab Among Postoperative Crohn’s Disease Patients as Postoperative Prophylaxis and Rescue Therapy: Real-world Data
doi : 10.1093/ibd/izae137
GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD
doi : 10.1093/ibd/izae250
Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment? Free
doi : 10.1093/ibd/izae069
Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab
doi : 10.1093/ibd/izae140
Distribution of Serum Testosterone Concentrations in IBD Males and Associations With Inflammatory Bowel Disease Activity
doi : 10.1093/ibd/izae177
The Composition of the Fecal and Mucosa-adherent Microbiota Varies Based on Age and Disease Activity in Ulcerative Colitis
doi : 10.1093/ibd/izae179
The Potential of Molecular Remission: Tissue Neutrophil Elastase Is Better Than Histological Activity for Predicting Long-Term Relapse in Patients With Ulcerative Colitis in Endoscopic Remission
doi : 10.1093/ibd/izae194
Macrophage-Derived Exosomes Promoted the Development and Stemness of Inflammatory Bowel Disease-Related Colorectal Cancer via nuclear paraspeckle assembly transcript 1-Mediated miRNA-34a-5p/phosphoprotein enriched in astrocytes 15 Axis
doi : 10.1093/ibd/izae212
The Effect of Colesevelam on the Microbiome in Postoperative Crohn’s Disease
doi : 10.1093/ibd/izae230
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired Open Access
doi : 10.1093/ibd/izae075
Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand Open Access
doi : 10.1093/ibd/izae087
New Insights into the Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Diseases: Focusing on Intestinal Smooth Muscle Cells
doi : 10.1093/ibd/izae292
Predictive Factors of Inactive Patient Participation in an Inflammatory Bowel Disease Learning Health System: A Longitudinal Cohort Study
doi : 10.1093/ibd/izae099
Treatment of Chronic Pouchitis With JAK Inhibitors: Results from A Large Multicenter Database
doi : 10.1093/ibd/izae116
Autologous Fat Grafting For Perianal Fistula in Behçet’s Disease: A Case Report
doi : 10.1093/ibd/izae157
Eco-gastroenterology in Inflammatory Bowel Disease Treatment: A Call for Sustainable Healthcare
doi : 10.1093/ibd/izae280
Limiting Opioid Use for Patients Who Are Hospitalized for Inflammatory Bowel Disease Exacerbations
doi : 10.1093/ibd/izae214
DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease
doi : 10.1093/ibd/izae234
Editorial Response to the Letter Relating to our Article “Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?�
doi : 10.1093/ibd/izae242
